NBCC’s mission is to end breast cancer through the power of education, action and advocacy. We have been revolutionizing the breast cancer community since our inception in 1991. As an organization, we have separated ourselves from the pack through our relentless work to support breast cancer research, to set the right scientific priorities and to bring the necessary people together to achieve significant progress in ending breast cancer. We are a dynamic, diverse coalition of hundreds of organizations and tens of thousands of individuals dedicated to giving breast cancer issues a meaningful voice in Washington, D.C., and state capitals, in laboratories and health care institutions and local communities everywhere.
Ensuring the Participation of Educated Patient Advocates in Science Research and All Levels of Health Care Decision Making: NBCC continues to work to ensure that educated patient advocates who represent a constituency have a meaningful seat at the table in all levels of health care decision making, which affects their lives, and we include this as one of our public policy priorities.
Breast cancer advocates who are trained, educated and represent a patient constituency must be meaningfully involved in all aspects of decision making that affect breast cancer research. This is the only way to ensure that funds are effectively spent and adequately address the causes and prevention of breast cancer, develop optimal treatments and cures for breast cancer, and focus on the best possible means to end the disease. Read our full position on advocate involvement.
NBCC works with a wide range of stakeholders, including corporations, industry, government, nongovernment organizations, researchers, scientists, breast cancer patients, caregivers and the public, to help raise awareness about and to end breast cancer. NBCC employs a specific approach to advocacy to ensure that our efforts will have a real impact and serve the best interests of women and men affected by breast cancer.
07/22/22In this week’s Science Spotlight, we examine two studies that look at changes over the last few decades in breast cancer mortality. We know that mortality rates have decreased. From NBCC’s perspective, the decrease is nowhere near commensurate with the investments to date, including financial, time, and people resources. But the question remains, what contributed to the decrease that did occur? Was it early detection? New treatments? Changes in how data are collected? Or improvements in access to care?
May 6-8, 2023, Lobby Day May 9, 2023
Park Hyatt Hotel
Save the Date for the 2023 Advocate Leadership Summit!
Mark your calendars for May 6-8, 2023! NBCC will once again be holding the Advocate Leadership Summit in Washington, DC at the Park Hyatt Hotel. Our annual Lobby Day will follow on May 9.
Planning has only just begun for the 2023 Summit, but we will continue to build on the strengths of the tireless and talented advocates who help NBCC achieve our mission to end breast cancer for everyone.
Stay tuned for more information!